Chemoenzymatic Synthesis of Modified 2′-Deoxy-2′-fluoro-β-d-arabinofuranosyl Benzimidazoles and Evaluation of their Activity Against Herpes Simplex Virus Type 1
Kharitonova, M.; Аntonov, K.; Fateev, I.; Berzina, .; Kaushin, A.; Paramonov, A.; Kotovskaya, S.; Аndronova, V.; Konstantinova, I.; Galegov, G.; Charushin, V.; Miroshnikov, A.
Synthesis 49(05): 1043-1052
2016
ISSN/ISBN: 0039-7881 Accession: 082391194
PDF emailed within 1 workday: $29.90
Related References
Nimmagadda, S.; Mangner, T.J.; Lawhorn-Crews, J.M.; Haberkorn, U.; Shields, A.F. 2009: Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-uracil) European Journal of Nuclear Medicine and Molecular Imaging 36(12): 1987-1993Schinazi, R.F.; Fox, J.J.; Watanabe, K.A.; Nahmias, A.J. 1986: Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2 Antimicrobial Agents and Chemotherapy 29(1): 77-84
Schinazi, R.F.; Fox, J.J.; Watanabe, K.A.; Nahmias, A.J. 1986: Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2 Antimicrobial Agents and Chemotherapy 29(1): 77-84
Schinazi, R.F.; Peters, J.; Sokol, M.K.; Nahmias, A.J. 1983: Therapeutic activities of 1 2 fluoro 2 deoxy beta d arabinofuranosyl 5 iodo cytosine and 1 2 fluoro 2 deoxy beta d arabinofuranosyl 5 iodo thymine alone and in combination with acyclovir and vidarabine in mice infected intra cerebrally with herpes simplex virus Antimicrobial Agents and Chemotherapy 24(1): 95-103
Trousdale, M.D.; Nesburn, A.B.; Su, T.L.; Lopez, C.; Watanabe, K.A.; Fox, J.J. 1983: Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes Antimicrobial Agents and ChemoTherapy 23(6): 808-813
Colacino, J.; Brownridge, E.; Greenberg, N.; Lopez, C. 1986: Enzymology and pathogenicity in mice of a herpes simplex virus type 1 mutant resistant to 2'-fluoro-2'-deoxy-1-beta-D-arabinofuranosyl-5-iodocytosine Antimicrobial Agents and ChemoTherapy 29(5): 877-882
Allaudeen, H.S.; Descamps, J.; Sehgal, R.K.; Fox, J.J. 1982: Selective inhibition of DNA replication in herpes simplex virus infected cells by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine Journal of Biological Chemistry 257(20): 11879-11882
Stuhmiller, L.M.; Hostetler, K.Y.; King, D.H. 1990: Synthesis and antiviral activity of phospholipid derivatives of 1 2 deoxy 2 fluoro beta d arabinofuranosyl 5 iodouracil fiau and 1 2 deoxy 2 fluoro beta d arabinofuranosyl 5 iodocytidine fiac Abstracts of Papers American Chemical Society 200(1-2): MEDI 134
Schinazi, R.F.; Peters, J.; Sokol, M.K.; Nahmias, A.J. 1983: Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus Antimicrobial Agents and ChemoTherapy 24(1): 95-103
Wigdahl, B.L.; Parkhurst, J.R. 1978: Inhibition of mouse l fibroblast cell and herpes simplex virus replication by 5 tri fluoro methyl 2 deoxy uridine role of l cell and herpes simplex virus induced deoxy thymidine kinase Abstracts of the Annual Meeting of the American Society for Microbiology 78: 8
Kharitonova, M.I.; Denisova, A.O.; Andronova, V.L.; Kayushin, A.L.; Konstantinova, I.D.; Kotovskaya, S.K.; Galegov, G.A.; Charushin, V.N.; Miroshnikov, A.I. 2017: New modified 2-aminobenzimidazole nucleosides: Synthesis and evaluation of their activity against herpes simplex virus type 1 Bioorganic and Medicinal Chemistry Letters 27(11): 2484-2487
Dziewiszek K.; Su T L.; Watanabe K.A. 1990: Derivatives of 1 2 deoxy 2 fluoro beta d arabinofuranosyl 5 phenyluracil and 1 2 deoxy 2 fluoro b d arabinofuranosyl 5 benzyluracil synthesis and some biological properties Abstracts of Papers American Chemical Society 200(1-2): MEDI 136
Nutter, R.L.; Rapp, F. 1972: The effect of beta d arabinofuranosyl cytosine on virus production in various cells infected with herpes simplex virus type 1 and herpes simplex virus type 2 Abstracts of the Annual Meeting of the American Society for Microbiology 72: 226
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Ma, T.; Lin, J.S.; Newton, M.G.; Cheng, Y.C.; Chu, C.K. 1997: Synthesis and anti-hepatitis B virus activity of 9-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl) purine nucleosides Journal of Medicinal Chemistry 40(17): 2750-2754
Srivastav, N.C.; Shakya, N.; Mak, M.; Agrawal, B.; Tyrrell, D.L.; Kumar, R. 2010: Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication Journal of Medicinal Chemistry 53(19): 7156-7166
Alauddin, M.M.; Shahinian, A.; Park, R.; Tohme, M.; Fissekis, J.D.; Conti, P.S. 2004: Synthesis of 2'-deoxy-2'-[18F]fluoro-5-bromo-1-beta-D-arabinofuranosyluracil ([18F]-FBAU) and 2'-deoxy-2'-[18F]fluoro-5-chloro-1-beta-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression Nuclear Medicine and Biology 31(4): 399-405
Rabenau, H. F.; Helmerich, A.; Weber, B. 1999: Verbesserte Labordiagnose der Herpes simplex Virus Infektion: Evaluierung eines modifizierten schnellen Shell-Vial-Assays zur Detektion und Typisierung von Herpes simplex Viren. Improved Laboratory Diagnosis of Herpes Simplex Virus Infection: Evaluation of a Modified Rapid Shell-Vial-Assay for the Detection and Typing of Herpes Simplex Virus Laboratoriums Medizin 23(11): 614-620
Borthwick, A.D.; Evans, D.N.; Kirk, B.E.; Biggadike, K.; Exall, A.M.; Youds, P.; Roberts, S.M.; Knight, D.J.; Coates, J.A. 1990: Fluoro carbocyclic nucleosides: synthesis and antiviral activity of 2'- and 6'-fluoro carbocyclic pyrimidine nucleosides including carbocyclic 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyluracil and carbocyclic 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil Journal of Medicinal Chemistry 33(1): 179-186
Wiegand, R.; Wu, J.; Shields, A.F.; Lorusso, P.; Li, J. 2012: Simultaneous determination of 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometry Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 891-892: 64-70